Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus - PubMed (original) (raw)

Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus

R Rahimian et al. Mol Cell Biochem. 2001 Aug.

Abstract

Studies of the molecular basis of insulin resistance have focused on the peroxisome proliferator activated receptor gamma (PPARgamma, gamma1 and gamma2). The aim of this study was to determine whether the insulin resistance in liver of diabetic animals is associated with abnormal expression of these receptors. PPARgamma mRNA and protein expression levels were quantified in liver of 9-week-old male ob/ob mice as a model of diabetes and compared to age- and gender-matched wild type control animals of the same genetic background. Semi-quantitative reverse transcription-polymerase chain reaction, using 18S rRNA as an internal standard, indicated that PPARgamma2 mRNA was significantly upregulated in ob/ob liver vs. that in wild type mice. Western blotting revealed greater immunoreactivity of PPARgamma2 in liver from ob/ob mice relative to that in wild type mice. An index of insulin resistance (product of serum glucose and insulin concentration) was correlated with liver PPARgamma2 mRNA expression (r = 0.776; p < 0.001). The findings that liver PPARgamma2 expression is (1) significantly elevated in the ob/ob model of diabetes and (2) positively associated with an index of insulin resistance, suggests a possible compensatory response through which type II diabetic and obese organisms strive to maintain insulin sensitivity of the liver.

PubMed Disclaimer

Cited by

Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice.
Wolf Greenstein A, Majumdar N, Yang P, Subbaiah PV, Kineman RD, Cordoba-Chacon J. Wolf Greenstein A, et al. J Endocrinol. 2017 Jan;232(1):107-121. doi: 10.1530/JOE-16-0447. Epub 2016 Oct 31. J Endocrinol. 2017. PMID: 27799461 Free PMC article.
Cerulenin blockade of fatty acid synthase reverses hepatic steatosis in ob/ob mice.
Cheng G, Palanisamy AP, Evans ZP, Sutter AG, Jin L, Singh I, May H, Schmidt MG, Chavin KD. Cheng G, et al. PLoS One. 2013 Sep 27;8(9):e75980. doi: 10.1371/journal.pone.0075980. eCollection 2013. PLoS One. 2013. PMID: 24086674 Free PMC article.
Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
Zhang W, Sun Q, Zhong W, Sun X, Zhou Z. Zhang W, et al. Alcohol Clin Exp Res. 2016 May;40(5):988-99. doi: 10.1111/acer.13049. Epub 2016 Apr 8. Alcohol Clin Exp Res. 2016. PMID: 27062444 Free PMC article.
Transcriptional regulation of glucose sensors in pancreatic β-cells and liver: an update.
Bae JS, Kim TH, Kim MY, Park JM, Ahn YH. Bae JS, et al. Sensors (Basel). 2010;10(5):5031-53. doi: 10.3390/s100505031. Epub 2010 May 19. Sensors (Basel). 2010. PMID: 22399922 Free PMC article. Review.
Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.
Matsusue K, Haluzik M, Lambert G, Yim SH, Gavrilova O, Ward JM, Brewer B Jr, Reitman ML, Gonzalez FJ. Matsusue K, et al. J Clin Invest. 2003 Mar;111(5):737-47. doi: 10.1172/JCI17223. J Clin Invest. 2003. PMID: 12618528 Free PMC article.

References

1. Diabetes. 1999 Apr;48(4):699-705 - PubMed
1. Lancet. 1995 Jul 8;346(8967):120-1 - PubMed
1. Nature. 1997 Mar 27;386(6623):407-10 - PubMed
1. J Clin Endocrinol Metab. 1998 Aug;83(8):2830-5 - PubMed
1. Metabolism. 1993 Oct;42(10):1365-9 - PubMed

Hepatic over-expression of peroxisome proliferator activated receptor gamma2 in the ob/ob mouse model of non-insulin dependent diabetes mellitus - PubMed (original) (raw)